-Cohort 10 news for Kevetrin -Phase 3 news for Brilacidin ABSSSI--FDA meeting outcomes including fast-track definitions -Phase 2 start and protocol Brilacidin OM--FDA meeting outcomes including fast-track definitions -Phase 2 or 2/3 news Prurisol-- -All 4 of the above.
Here's what we got:
-Positive Results of Brilacidin in Microbiological Intent-to-Treat Population in Phase 2b ABSSSI Trial -Additional Pharmacokinetic Information to Be Submitted. -IRB Approval to Start Oral Mucositis Trial -Grant Awarded for HDP Mimics -Biotech Showcase on Tap
Definitely not fluff. Definitely not what we were expecting.
You're not the least bit disappointed?
As always, in my opinion only. Do your own due diligence!